Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-29
DOI
10.3389/fendo.2022.1002916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
- (2022) Manoj Kumar Mahapatra et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
- (2021) Johanna C. Arroyave-Ospina et al. Antioxidants
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Is the Mediterranean Diet the Best Approach to NAFLD Treatment Today?
- (2021) Francesco Angelico et al. Nutrients
- Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double‐Blind Phase 2 Trial
- (2021) Samer Gawrieh et al. HEPATOLOGY
- Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers
- (2021) Philipp Kasper et al. Cells
- A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage
- (2021) Suling Huang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
- (2021) Olivier Govaere et al. JOURNAL OF HEPATOLOGY
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD
- (2021) Jie Zhang et al. Science Advances
- Diet and the Human Gut Microbiome: An International Review
- (2020) Annette S. Wilson et al. DIGESTIVE DISEASES AND SCIENCES
- Therapeutic potential of PPARγ natural agonists in liver diseases
- (2020) Liwei Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Update on NAFLD genetics: from new variants to the clinic
- (2020) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
- (2020) Peng Zhao et al. SCIENCE
- Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
- (2020) Björn Carlsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
- (2020) Sander Lefere et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
- (2020) Hui-Ting Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet
- (2020) Jose Cordoba-Chacon PPAR Research
- Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Xiongfeng Pan et al. Scientific Reports
- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
- (2020) Daniela Maria Tanase et al. Journal of Diabetes Research
- Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output
- (2020) Qiyi Zhao et al. CELL
- High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms
- (2020) Cai-Yu Lian et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
- (2020) André J. Scheen Nature Reviews Endocrinology
- Discovery and Targeting of the Signaling Controls of PNPLA3 to Effectively Reduce Transcription, Expression, and Function in Pre-Clinical NAFLD/NASH Settings
- (2020) Brian E. Schwartz et al. Cells
- Salsalate reverses metabolic disorders in a mouse model of non‐alcoholic fatty liver disease through AMPK activation and caspase‐6 activity inhibition
- (2020) Jingjing Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- A High-Fat Diet Attenuates Amp-Activated Protein Kinase α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development in Vivo
- (2020) Chenghui Yan et al. DIABETES
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2020) Alessandro Mantovani et al. Metabolites
- Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice
- (2020) Tiego Aparecido Diniz et al. LIFE SCIENCES
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of Nonalcoholic Fatty Liver Disease: a 2018 Update.
- (2019) Luca VC Valenti et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial
- (2019) Yi Wan et al. GUT
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Serum coding and non‐coding RNA s as biomarkers of NAFLD and fibrosis severity
- (2019) Stefania Di Mauro et al. LIVER INTERNATIONAL
- A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non‐Alcoholic Fatty Liver Disease
- (2019) Petar Dianov Petrov et al. MOLECULAR NUTRITION & FOOD RESEARCH
- 15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
- (2019) Jingjing Li et al. PPAR Research
- Short-Term Activation of Peroxisome Proliferator-Activated Receptors α and γ Induces Tissue-Specific Effects on Lipid Metabolism and Fatty Acid Composition in Male Wistar Rats
- (2019) Elin Strand et al. PPAR Research
- Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
- (2019) Dimitrios A. Koutoukidis et al. JAMA Internal Medicine
- Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives
- (2019) Natalia Vallianou et al. Current Obesity Reports
- Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease
- (2019) Nienke Koopman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Biochemical basis and metabolic interplay of redox regulation
- (2019) Lixiao Zhang et al. Redox Biology
- Protective effect of metformin against palmitate-induced hepatic cell death
- (2019) Yana Geng et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- PNPLA3 I148M and liver fat and fibrosis scores predict liver disease mortality in the United States population
- (2019) Aynur Unalp‐Arida et al. HEPATOLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- Adaptive immunity: an emerging player in the progression of NAFLD
- (2019) Salvatore Sutti et al. Nature Reviews Gastroenterology & Hepatology
- Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
- (2019) Chencheng Xie et al. Nutrients
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
- (2018) Xinshou Ouyang et al. Cell Metabolism
- Reactive Oxygen Species in Metabolic and Inflammatory Signaling
- (2018) Steven J. Forrester et al. CIRCULATION RESEARCH
- The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
- (2018) Christina C. Lindenmeyer et al. Clinics in Liver Disease
- The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
- (2018) Pengfei Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Keeping the home fires burning: AMP-activated protein kinase
- (2018) D. Grahame Hardie Journal of the Royal Society Interface
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
- (2018) Liping Zhao et al. SCIENCE
- Effects of liraglutide, metformin, and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial
- (2018) Wen-Huan Feng et al. Journal of Diabetes Investigation
- The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis
- (2018) Feng-Bin Lu et al. Expert Review of Gastroenterology & Hepatology
- AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
- (2018) Nadia Boudaba et al. EBioMedicine
- Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study
- (2018) Jan Oscarsson et al. Journal of Clinical Lipidology
- Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
- (2018) Di Wu et al. NATURE
- Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
- (2018) Ruiting Han et al. Frontiers of Medicine
- Control and dysregulation of redox signalling in the gastrointestinal tract
- (2018) Eric L. Campbell et al. Nature Reviews Gastroenterology & Hepatology
- Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
- (2018) David Porras et al. Frontiers in Physiology
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
- (2017) Cyrielle Caussy et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids
- (2017) Aafke W. F. Janssen et al. JOURNAL OF LIPID RESEARCH
- AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
- (2017) Daniel Garcia et al. MOLECULAR CELL
- Fighting the fatty liver
- (2017) Liam Drew NATURE
- Nuclear receptors and nonalcoholic fatty liver disease 1 1This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie.
- (2016) Matthew C. Cave et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
- (2016) D. Grahame Hardie et al. TRENDS IN CELL BIOLOGY
- Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
- (2015) Venkatanarayana Gangarapu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial
- (2015) Eleonora Scorletti et al. JOURNAL OF HEPATOLOGY
- Insulin inhibits AMPK activity and phosphorylates AMPK Ser485/491 through Akt in hepatocytes, myotubes and incubated rat skeletal muscle
- (2014) Rudy J. Valentine et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- PNPLA3gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
- (2014) Jiayun Shen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
- (2014) Thomas Svava Nielsen et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice
- (2014) Yvonne Ritze et al. PLoS One
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Autophagy protects against palmitate-induced apoptosis in hepatocytes
- (2014) Ning Cai et al. Cell and Bioscience
- Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
- (2013) Rebecca Taub et al. ATHEROSCLEROSIS
- Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects
- (2013) Rajendra H. Jani et al. CLINICAL DRUG INVESTIGATION
- Cyclooxygenase-2 Promotes Hepatocellular Apoptosis by Interacting with TNF-α and IL-6 in the Pathogenesis of Nonalcoholic Steatohepatitis in Rats
- (2013) Qi Cheng et al. DIGESTIVE DISEASES AND SCIENCES
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
- (2013) Akinobu Takaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
- (2013) Marno C. Ryan et al. JOURNAL OF HEPATOLOGY
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Nutrient Sensing, Metabolism, and Cell Growth Control
- (2013) Hai-Xin Yuan et al. MOLECULAR CELL
- Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
- (2013) Morgan D Fullerton et al. NATURE MEDICINE
- China in the period of transition from scarcity and extensive undernutrition to emerging nutrition-related non-communicable diseases, 1949-1992
- (2013) S. F. Du et al. Obesity Reviews
- Structural basis of AMPK regulation by small molecule activators
- (2013) Bing Xiao et al. Nature Communications
- Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
- (2012) Tiphaine Le Roy et al. GUT
- Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
- (2012) Shira Zelber-Sagi et al. JOURNAL OF HEPATOLOGY
- Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
- (2012) X. Julia Xu et al. JOURNAL OF LIPID RESEARCH
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Phosphorylation Regulates Assembly of the Caspase-6 Substrate-Binding Groove
- (2012) Elih M. Velázquez-Delgado et al. STRUCTURE
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Stimulation of Human Whole-Body Energy Expenditure by Salsalate Is Fueled by Higher Lipid Oxidation under Fasting Conditions and by Higher Oxidative Glucose Disposal under Insulin-Stimulated Conditions
- (2011) Ruth C. R. Meex et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver
- (2011) Mohamed A. Abdelmegeed et al. JOURNAL OF NUTRITION
- Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin–glucan fiber improves host metabolic alterations induced by high-fat diet in mice
- (2011) Audrey M. Neyrinck et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans
- (2010) Marie-Soleil Gauthier et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMPK inhibition in health and disease
- (2010) Benoit Viollet et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis
- (2010) Samar H. Ibrahim et al. JOURNAL OF HEPATOLOGY
- The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease
- (2009) Patrice Cani et al. CURRENT PHARMACEUTICAL DESIGN
- c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice
- (2009) Yuzo Kodama et al. GASTROENTEROLOGY
- AMPK in Health and Disease
- (2009) Gregory R. Steinberg et al. PHYSIOLOGICAL REVIEWS
- Role of PPARs in Radiation-Induced Brain Injury
- (2009) Sriram Ramanan et al. PPAR Research
- Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
- (2008) Allison B. Goldfine et al. CTS-Clinical and Translational Science
- Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients
- (2008) H. Boon et al. DIABETOLOGIA
- Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
- (2008) Ina Bergheim et al. JOURNAL OF HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now